HARROW INC. - COMMON STOCK

Harrow Announces Second-Quarter 2025 Financial Results

11 أغسطس 2025 13:01:00 بحسب Nasdaq GlobeNewswire

Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference

06 أغسطس 2025 04:00:00 بحسب Nasdaq GlobeNewswire

Harrow To Report Second Quarter 2025 Financial Results After Market Close on August 11, 2025

29 يوليو 2025 04:00:00 بحسب Nasdaq GlobeNewswire

Harrow Health to Announce Second Quarter 2021 Financial Results on August 10, 2021

26 يوليو 2021 06:00:00 بحسب Nasdaq GlobeNewswire

Harrow Health Granted Two Patents for Novel Surgical Dilation Formulation

15 يوليو 2021 05:00:01 بحسب Nasdaq GlobeNewswire

Harrow Health Announces Closing of $20 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026

17 يونيو 2021 13:01:00 بحسب Nasdaq GlobeNewswire

Harrow Health Announces Pricing of $17.5 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026

14 يونيو 2021 14:59:19 بحسب Nasdaq GlobeNewswire

Harrow Health Announces Offering of $17.5 Million of 8.625% Senior Notes Due 2026 and “BB” Rating from Egan-Jones

14 يونيو 2021 04:45:00 بحسب Nasdaq GlobeNewswire

Harrow Health Launches New Corporate and Investor Website

01 يونيو 2021 06:00:00 بحسب Nasdaq GlobeNewswire

Leading Peer-Reviewed Ophthalmic Journal Publishes Study on ImprimisRx’s Proprietary Klarity-C® Drops

17 مايو 2021 06:00:00 بحسب Nasdaq GlobeNewswire

Harrow Health Announces Record First Quarter 2021 Financial Results

11 مايو 2021 13:01:00 بحسب Nasdaq GlobeNewswire

Harrow Health Raises Approximately $11 Million in Sale of Series B Preferred Stock

05 مايو 2021 13:03:00 بحسب Nasdaq GlobeNewswire

Harrow Health Announces Full Exercise and Closing of Option to Purchase Additional Senior Notes

05 مايو 2021 13:01:00 بحسب Nasdaq GlobeNewswire

Harrow Health to Announce First Quarter 2021 Financial Results on May 11, 2021

27 أبريل 2021 06:00:01 بحسب Nasdaq GlobeNewswire

Harrow Health Announces Closing of $50 Million Offering of Senior Notes Due 2026

20 أبريل 2021 13:01:00 بحسب Nasdaq GlobeNewswire

Harrow Health Announces Pricing of $50 Million Offering of Senior Notes Due 2026

15 أبريل 2021 14:00:00 بحسب Nasdaq GlobeNewswire

Harrow Health Announces Offering of $25 Million Senior Notes Due 2026 and “BB” Rating from Egan-Jones

14 أبريل 2021 13:01:00 بحسب Nasdaq GlobeNewswire

Harrow Health Announces Preliminary First Quarter 2021 Financial Results

14 أبريل 2021 13:00:00 بحسب Nasdaq GlobeNewswire

Harrow Health Announces Fourth Quarter and Year-End 2020 Financial Results

08 مارس 2021 13:01:00 بحسب Nasdaq GlobeNewswire

Harrow Health to Participate in H.C. Wainwright Global Life Sciences Conference

02 مارس 2021 06:00:01 بحسب Nasdaq GlobeNewswire